Ketasyn in Mild to Moderate Alzheimer's Disease

This study has been completed.

Sponsor:

Information provided by:

National Institute on Aging (NIA)

ClinicalTrials.gov Identifier:

NCT00142805

First received: September 1, 2005

Last updated: December 30, 2008

Last verified: September 2006

History of Changes

Full Text View
Tabular View
No Study Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	March 2006
Estimated Primary Completion Date:	No date given

No publications provided by National Institute on Aging (NIA)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Henderson ST, Poirier J. Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study. BMC Med Genet. 2011 Oct 12;12:137.

To Top